News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InterBioScreen And Quantum Pharmaceuticals Announce A Joint Project To Develop A Revolutionary Drug Discovery Product


10/19/2005 5:08:46 PM

Moscow, Russia. August 1, 2004 -- InterBioScreen (IBS), global provider of unique chemical compound libraries, and Quantum Pharmaceuticals, high-tech drug discovery company, announced a new project to create a revolutionary product for the drug discovery market.

The joint project, QuantumLead, combines the industry leading in silico lead optimization technology of Quantum Pharmaceuticals with the unique synthetic and natural compound libraries and network of scientists of IBS to create Q-Lead-Libraries.

Q-Lead-Libraries are libraries of compounds, which are ranked according to their constant affinity to particular protein targets. They are designed to allow biotech and pharmaceutical companies to achieve a dramatic acceleration of the drug discovery R&D process by reducing or eliminating the time involved in screening and optimization of hits and leads. Using Q-Lead Libraries will enable biotech and pharmaceuticals companies to find exclusive novel drug candidates more quickly and at a lower cost.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES